BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 34342367)

  • 1. The current situation of health services for hydatidiform mole in Cambodia.
    Yamamoto E; Kanal K; Soeung SC; Fujita N; Krang S; Long-Hay P; Nishino K; Niimi K; Hamajima N
    J Obstet Gynaecol Res; 2021 Oct; 47(10):3652-3660. PubMed ID: 34342367
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multiple pregnancy with complete hydatidiform mole and coexisting normal fetus in a retrospective cohort of 141 patients.
    Hajri T; Massoud M; Vergne M; Descargues P; Allias F; You B; Lotz JP; Haesebaert J; Bolze PA; Golfier F; Massardier J
    Am J Obstet Gynecol; 2024 Mar; 230(3):362.e1-362.e8. PubMed ID: 37722570
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The management of hydatidiform mole using prophylactic chemotherapy and hysterectomy for high-risk patients decreased the incidence of gestational trophoblastic neoplasia in Vietnam: a retrospective observational study.
    Yamamoto E; Trinh TD; Sekiya Y; Tamakoshi K; Nguyen XP; Nishino K; Niimi K; Kotani T; Kajiyama H; Shibata K; Le QT; Kikkawa F
    Nagoya J Med Sci; 2020 May; 82(2):183-191. PubMed ID: 32581399
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epidemiologic study on gestational trophoblastic diseases in Japan.
    Yamamoto E; Nishino K; Niimi K; Ino K
    J Gynecol Oncol; 2022 Nov; 33(6):e72. PubMed ID: 36047375
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Case of Rapid Transformation from Hydatidiform Mole to Invasive Mole: The Importance of β-hCG (Human Chorionic Gonadotropin) Serum Levels in Follow-Up Evaluation.
    Harsono AB; Hidayat YM; Winarno GNA; Nisa AS; Alkaff FF
    Am J Case Rep; 2021 Jun; 22():e931156. PubMed ID: 34127641
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Does a human chorionic gonadotropin level of over 20,000 IU/L four weeks after uterine evacuation for complete hydatidiform mole constitute an indication for chemotherapy for gestational trophoblastic neoplasia?
    Braga A; Biscaro A; do Amaral Giordani JM; Viggiano M; Elias KM; Berkowitz RS; Seckl MJ
    Eur J Obstet Gynecol Reprod Biol; 2018 Apr; 223():50-55. PubMed ID: 29477553
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Surgery including fertility-sparing treatment of GTD.
    Ngu SF; Ngan HYS
    Best Pract Res Clin Obstet Gynaecol; 2021 Jul; 74():97-108. PubMed ID: 33127305
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gestational trophoblastic disease: experience at Nawabshah Hospital.
    Nizam K; Haider G; Memon N; Haider A
    J Ayub Med Coll Abbottabad; 2009; 21(1):94-7. PubMed ID: 20364752
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epidemiology and time trends of gestational trophoblastic disease in Korea.
    Kim SJ; Bae SN; Kim JH; Kim CJ; Han KT; Chung JK; Lee JM
    Int J Gynaecol Obstet; 1998 Apr; 60 Suppl 1():S33-8. PubMed ID: 9833613
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Survey of gestational trophoblastic disease incidence among 3.6 million pregnancies in China].
    Shi YF; Li JQ; Zheng W; Chen XJ; Qiao YH; Hao M; Zhou CW; Hu YL; Wan GM; Sha YC; Zheng X
    Zhonghua Fu Chan Ke Za Zhi; 2005 Feb; 40(2):76-8. PubMed ID: 15840282
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gestational trophoblastic diseases - clinical guidelines for diagnosis, treatment, follow-up, and counselling.
    Niemann I; Vejerslev LO; Frøding L; Blaakær J; Maroun LL; Hansen ES; Grove A; Lund H; Havsteen H; Sunde L
    Dan Med J; 2015 Nov; 62(11):A5082. PubMed ID: 26522484
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Experience of women on the Irish National Gestational Trophoblastic Disease Registry.
    Joyce CM; Coulter J; Kenneally C; McCarthy TV; O'Donoghue K
    Eur J Obstet Gynecol Reprod Biol; 2022 May; 272():206-212. PubMed ID: 35367922
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gestational trophoblastic neoplasia after spontaneous human chorionic gonadotropin normalization following molar pregnancy evacuation.
    Braga A; Maestá I; Matos M; Elias KM; Rizzo J; Viggiano MG
    Gynecol Oncol; 2015 Nov; 139(2):283-7. PubMed ID: 26383828
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Surveillance for gestational trophoblastic neoplasia following molar pregnancy: a cost-effectiveness analysis.
    Albright BB; Myers ER; Moss HA; Ko EM; Sonalkar S; Havrilesky LJ
    Am J Obstet Gynecol; 2021 Nov; 225(5):513.e1-513.e19. PubMed ID: 34058170
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hormonal contraceptive use before hCG remission does not increase the risk of gestational trophoblastic neoplasia following complete hydatidiform mole: a historical database review.
    Braga A; Maestá I; Short D; Savage P; Harvey R; Seckl MJ
    BJOG; 2016 Jul; 123(8):1330-5. PubMed ID: 26444183
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gestational trophoblastic neoplasia after achieving a nondetectable serum human chorionic gonadotrophin level.
    Gueye M; Kane-Gueye SM; Ndiaye-Gueye MD; Mbaye M; Diouf AA; Niang MM; Diallo M; Moreau JC
    BJOG; 2014 Oct; 121(11):1415-9. PubMed ID: 24674295
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Changing presentation of complete hydatidiform mole at the New England Trophoblastic Disease Center over the past three decades: does early diagnosis alter risk for gestational trophoblastic neoplasia?
    Sun SY; Melamed A; Goldstein DP; Bernstein MR; Horowitz NS; Moron AF; Maestá I; Braga A; Berkowitz RS
    Gynecol Oncol; 2015 Jul; 138(1):46-9. PubMed ID: 25969351
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epidemiology of Hydatidiform Moles in a Tertiary Hospital in Thailand over Two Decades: Impact of the National Health Policy.
    Wairachpanich V; Limpongsanurak S; Lertkhachonsuk R
    Asian Pac J Cancer Prev; 2015; 16(18):8321-5. PubMed ID: 26745079
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Advances in diagnostics and management of gestational trophoblastic disease.
    Lukinovic N; Malovrh EP; Takac I; Sobocan M; Knez J
    Radiol Oncol; 2022 Dec; 56(4):430-439. PubMed ID: 36286620
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Do we need post-pregnancy screening with human chorionic gonadotrophin after previous hydatidiform mole to identify patients with recurrent gestational trophoblastic disease?
    Earp KE; Hancock BW; Short D; Harvey RA; Fisher RA; Drew D; Sarwar N; Tidy JA; Winter MC; Chien P; Seckl MJ
    Eur J Obstet Gynecol Reprod Biol; 2019 Mar; 234():117-119. PubMed ID: 30684876
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.